Markets:

Overview

News

Currencies

International

Treasuries

Puma Biotechnology Inc - Common Stock (NQ:PBYI)

7.690 +0.180 (+2.40%)

Streaming Delayed Price Updated: 12:01 PM EDT, Apr 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Puma Biotechnology Inc - Common Stock

< Previous 1 2 3 Next >

As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors? ↗

March 23, 2026

This clinical-stage biotech develops therapies for NASH and obesity, advancing a pipeline of proprietary small-molecule drug candidates.

Via The Motley Fool

Puma Biotechnology (NASDAQ:PBYI) Beats Q4 Estimates, Guides for Profitable 2026 ↗

February 26, 2026

Via Chartmill

Puma Biotech (PBYI) Earnings Call Transcript ↗

February 26, 2026

Puma Biotech (PBYI) Earnings Call Transcript

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 10, 2025

Via Benzinga

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Where Puma Biotechnology Stands With Analysts ↗

July 26, 2024

Via Benzinga

Puma Biotechnology (NASDAQ:PBYI) Tops Q3 2025 Estimates and Raises Full-Year Outlook ↗

November 06, 2025

Puma Biotech's Q3 2025 earnings beat expectations, driven by strong NERLYNX sales. The company raised its full-year revenue guidance and advances its clinical pipeline.

Via Chartmill

Topics Earnings

Puma (PBYI) Q2 Revenue Rises 11% ↗

August 08, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 01, 2024

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock ↗

June 04, 2024

Via Benzinga

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute ↗

May 20, 2024

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Via Benzinga

Topics Intellectual Property

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Why Shares of Puma Biotechnology Rose This Week ↗

December 15, 2022

The company's CEO bought $2.5 million worth of company stock.

Via The Motley Fool

PBYI Stock Earnings: Puma Biotechnology Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

PBYI stock results show that Puma Biotechnology beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

7 Stocks Under $15 Predicted to Boom in the Next 2 Years ↗

April 19, 2024

Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 14, 2024

Via Benzinga

3 Strong Buy Stocks Under $5: January 2024 ↗

January 31, 2024

A strong buy rating carries weight which speculative investors may want to research in these strong buy stocks under $5.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 24, 2023

Via Benzinga

Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗

July 20, 2023

Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

July 20, 2023

It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 05, 2023

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

7 A-Rated Penny Stocks Worth Betting On ↗

February 19, 2023

Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance.

Via InvestorPlace

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 03, 2023

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 26, 2022

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Penticton Herald

Penticton Herald

Puma Biotechnology Inc - Common Stock (NQ:PBYI)

Headline News about Puma Biotechnology Inc - Common Stock

Contact us

Sections

Services

Search